Resolve Therapeutics
CEO and Co-founder at Resolve Therapeutics, LLC.
Developing a drug for Lupus.
Launch date
Employees
Market cap
-
Enterprise valuation
$23—35m (Dealroom.co estimates Nov 2012.)
Kirkland Washington (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$2.0m | Series A | ||
N/A | $1.1m | Debt | |
$5.8m | Series B | ||
Total Funding | $7.8m |
Related Content
Recent News about Resolve Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.